Journal of Clinical Virology
Volume 37, Issue 1 , Pages 72-74, September 2006

A novel mutation of varicella-zoster virus associated to fatal hepatitis

  • Silvia Natoli

      Affiliations

    • Istituto di Anestesia e Rianimazione, Università di Roma Tor Vergata, Policlinico di Tor Vergata, Viale Oxford 81, 00133 Rome, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 06 20900754; fax: +39 06 72596006.
  • ,
  • Marco Ciotti

      Affiliations

    • Laboratorio di Microbiologia e Virologia Clinica, Università di Roma Tor Vergata, Policlinico di Tor Vergata, Rome, Italy
  • ,
  • Pierpaolo Paba

      Affiliations

    • Laboratorio di Microbiologia e Virologia Clinica, Università di Roma Tor Vergata, Policlinico di Tor Vergata, Rome, Italy
  • ,
  • Gian Piero Testore

      Affiliations

    • Dipartimento di Sanità Pubblica, Cattedra di Malattie Infettive, Università di Roma Tor Vergata, Policlinico di Tor Vergata, Rome, Italy
  • ,
  • Giampiero Palmieri

      Affiliations

    • Cattedra di Anatomia Patologica, Università di Roma Tor Vergata, Policlinico di Tor Vergata, Rome, Italy
  • ,
  • Augusto Orlandi

      Affiliations

    • Cattedra di Anatomia Patologica, Università di Roma Tor Vergata, Policlinico di Tor Vergata, Rome, Italy
  • ,
  • Alessandro Fabrizio Sabato

      Affiliations

    • Istituto di Anestesia e Rianimazione, Università di Roma Tor Vergata, Policlinico di Tor Vergata, Viale Oxford 81, 00133 Rome, Italy
  • ,
  • Francesca Leonardis

      Affiliations

    • Istituto di Anestesia e Rianimazione, Università di Roma Tor Vergata, Policlinico di Tor Vergata, Viale Oxford 81, 00133 Rome, Italy

Received 27 December 2005; received in revised form 5 May 2006; accepted 13 June 2006. published online 31 July 2006.

Abstract 

Background

Lethal varicella in immunocompetent hosts is rare and its pathogenesis is largely unknown. The discovery of glycoprotein E (gE) mutants showing attributes consistent with increased virulence in vitro and in animal models, provided a possible molecular mechanism underlying a more aggressive virus infection. However, these mutants have never been associated with unusually severe clinical cases.

Objectives

To varicella-zoster virus (VZV) mutations that correlate with increased virulence.

Results

We report a case of fatal hepatitis caused by a VZV bearing a novel mutation on the 3B3 monoclonal antibody epitope of gE in an immunocompetent host.

Conclusions

This report describes a mutant VZV responsible for an aggressive clinical course in an immunocompetent host. Linking these severe clinical presentations of VZV infection to virus mutations might provide insights into the underlying pathogenic mechanisms.

Keywords: Varicella hepatitis, VZV thymidine kinase mutant virus, Severe varicella

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1386-6532(06)00198-3

doi:10.1016/j.jcv.2006.06.004

Journal of Clinical Virology
Volume 37, Issue 1 , Pages 72-74, September 2006